3 European Projects Found
Searched on 125080 European Projects
FINISHED
"Generation and Evaluation of ""Next-generation"" Antibody-Toxin-Conjugates for Cancer Therapy" (MABTOX)
Start date: Oct 1, 2013, End date: Dec 31, 2015,
Therapeutic antibodies have transformed cancer therapy during the last decade, due to their high selectivity of targeting cancer cells in comparison to standard small molecule chemotherapy. Most recently, the coupling of cellular toxins to therapeutic antibodies has demonstrated an even greater efficacy in the therapy of cancer and the first, highly potent antibody drug conjugate (ADC), Adcetris®, ...
Read Project
12
Partners Participants
FINISHED
Lipid droplets as dynamic organelles of fat deposition and release: Translational research towards human disease (LipidomicNet)
Start date: May 1, 2008, End date: Oct 31, 2012,
Lipids are central to the regulation and control of cellular processes by acting as basic building units for biomembranes, the platforms for the vast majority of cellular functions. Recent developments in lipid mass spectrometry have set the scene for a completely new way to understand the composition of membranes, cells and tissues in space and time by allowing the precise identification and quan ...
Read Project
27
Partners Participants
FINISHED
European Consortium for Anticancer Antibody Development (EUCAAD)
Start date: May 1, 2008, End date: Apr 30, 2012,
Cancer is the second leading cause of death in European countries, and one of the most imminent health problems in the developed world. Innovative, so-called targeted therapies are urgently needed that aim specifically at cancer cells or to cells of the stroma that support tumor growth. The ultimate goal of a targeted therapy is to increase anti-tumor efficacy with lowest possible side effects. R ...
Read Project
